Payment & Shipping Terms:
|Product Name:||ACP-105||Packaging:||Foil Bag|
|Appearance:||Yellow To Pale Yellow Crystalline Powder||Assays:||99%|
pharma raw materials,
steroid raw powder
Newest sarms ACP105 / SARMS / ACP-105 / acp 105 new product
1. ACP105 description:
Product Specification : 98%
Minmum Order Quantity : >50g
Sample Requirement : Free Sample / Freight Charged / to final agreement
Product No.: PURACP
2. ACP105 COA:
|Appearance||A white crystalline powder||
|Loss on drying||NMT0.5%||0.07%|
|Assay(On dry basis)||99.0%-101.0%||99.58%|
|Microbiology||Total bacterial count:<1000CFU/g||30CFU/g|
|Total Fungus count: <100CFU/g||<10 CFU/g|
|Escherichia coli:Not detected||Not detected|
3. ACP-105, a Novel Non-Steroidal SARM:
In a poster presentation titled, "In Vitro and In Vivo Profile of a Novel Tissue Selective, Orally Bioavailable Non-Steroidal Androgen Receptor Modulator," ACADIA researchers present findings on ACP-105, a novel non-steroidal SARM.ACP-105 is shown to be as potent and efficacious as testosterone in in vitro assays without interaction at other hormone receptors. In addition, ACP-105 demonstrates potent anabolic effects on muscle and bone with minimal effect on prostrate in preclinical models.
4. About ACP-105:
ACP-105 is a non-steroidal and selective androgen receptor agonist. ACP-105 is part of a class of molecules referred to as selective androgen receptor modulators (SARMs). SARMs may advance the standard of treatment for a variety of disorders including muscle-wasting conditions and osteoporosis, with fewer side effects as compared to current treatments based on testosterone replacement. ACP-105 has exhibited promising pharmacological properties and a favorable safety profile in preclinical testing.
5. ACP105 Function:
Anabolism - promotion and growth of lean muscle tissue and mass. This is extremely important for the individual suffering from a muscle wasting disease. It is the muscle wasting that at times can lead to the demise of the patient even before the disease itself.
Increases in strength - again, excellent for those suffering from muscle wasting diseases.
Increased bone density and strength - highly beneficial to the osteoporosis patient. SARMS may prove to be one of if not the most effective osteoporosis treatments available, although official data is still inconclusive.
Fat Loss - medications with strong androgen binding affinity have been shown to promote lipolysis. How significant these six SARMS are in this regard is inconclusive.
Low to No Virilization - this is highly important to women. Many compounds (anabolicandrogenic steroids) while the same benefits of anabolic steroids can apply to women as they do men, there is often the issue of virilization. Virilization refers to the promotion of masculine like traits in women, i.e. body hair growth, a deepening of the vocal chords and clitoral enlargement. SARMS have been shown to NOT promote virilization symptoms in women. Existing data supports that the pre-clinical SARMS should be no different, although again at this stage is not fully conclusive.
Increased Libido (Females) - preliminary data, especially in regards to AC-262,356 has shown the SARM may increase female libido significantly.
Contraceptive (Males) - preliminary data, especially in regards to S-23 has shown the SARM may be an effective male contraceptive.
Endurance & Conditioning - All of the pre-clinical SARMS should have a level of positive effect on muscular endurance as well as overall physical conditioning. The level of effectiveness in such regards is dependent on the SARM in question and data is still inconclusive to quantify the total effects.
Nutrient Efficiency - All of the pre-clinical SARMS should have a positive impact on nutrient efficiency to one degree or another. This refers to the ability of the body to make better use of the nutrients it consumes.
Estrogen and DHT - The pre-clinical SARMS should not aromatize, referring to the promotion of the testosterone to estrogen conversion. However, some increases in serum estrogen levels may be possible depending on the SARM. Dihydrotestosterone (DHT) related side effects (hair loss, acne) are also not possible with these SARMS. There should also be little to no negative affect on the prostate; in fact, data shows potential prostate health improvement.
6. Other related products:
|4 of 10||acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown|
|MK2866||7 of 10||medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy.|
|MK-677||5 of 10||treatment of obesity, a promising therapy for the treatment of frailty in the elderly|
|LGD-4033||7 of 10||pharmacological profile similar to that of enobosarm, Ostarine,MK-2866|
|GW501516||7 of 10||For obesity, diabetes, dyslipidemia and cardiovascular disease|
|Andarine(S4)||7 of 10||partial agonist, intended mainly for treatment of benign prostatic hypertrophy|
|SR9009||under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice|
|SR9011||For obesity, diabetes, dyslipidemia and cardiovascular disease|
|RAD140||5 of 10||New generation for gaining mass and cutting edges|
|YK11||7 of 10||a SARM and myostatin inhibitor in one|
|14)7-keto(7-keto DHEA , 5-Androsten-3β-ol-7,17-dione)|
|16)6OXO(4- androstene-3,6,17- trione)|
|28)7b -Hydroxy-17b -Dihydro-DHEA|
|33)Stanozolol USP28 (97.0%-102.0%)|
|34)Oxymetholone USP28 (97.0%-103.0%)|
|35)Oxandrolone USP28 (97.0%-102.0%)|
|36)Methandrostenolone BP2000 (98.5%)|
|37)Testosterone Enanthate USP28 (98.0%)|
|38)Testosterone Propionate USP28 (97.0%-102.0%)|
|39)Testesterone Cypionate USP28 (97.0%-102.0%)|
|40)DECA (18-Methylest-4-en-3-one-17B-ol) also known as Nandronone Decanoate|
|43)Drostanolone Di Propionate|
|51)(Phera)Methandrostenolone BP2000 (98.5%)|
7, Our advantate:
1. Technical consultancy, to help customer know about the properties, features, quality, production and supply of the product they want.
2. Technical information and documents, such as COA, test report, sample etc.
3. Customers are welcome to visit our factory and negotiate with us at any time.
1. Sign contract with customer, negotiating price, quality, delivery and other terms.
2.Answer the questions concerning properties, mechanism, application, quality, attention, usage etc. of the product.
3. Production schedule and on time delivery after signing contract.
1. Technical consultancy during use of the product.
2. Customer can return or exchange the merchandise with us if they need to change purchase plan due to some reasonable reasons, on condition that the product is not damaged.
3. If quality problems occur during normal use, please send us written information and documents, and we will respond within 24-48 hours.
Our R&D (research and development) center has around 1,000 square meters synthesis and testing laboratory, meets industrial standards, equipped with first class research facilities and powerful technical team.
Contact Person: Clara